{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T20:31:48Z","timestamp":1786653108280,"version":"build-2736575974"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J App Basic Med Res"],"published-print":{"date-parts":[[2015]]},"DOI":"10.4103\/2229-516x.157162","type":"journal-article","created":{"date-parts":[[2015,5,15]],"date-time":"2015-05-15T08:11:40Z","timestamp":1431677500000},"page":"114","source":"Crossref","is-referenced-by-count":13,"title":["Comparative efficacy of methylphenidate and atomoxetine in oppositional defiant disorder comorbid with attention deficit hyperactivity disorder"],"prefix":"10.4103","volume":"5","author":[{"given":"Jasmin","family":"Garg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priti","family":"Arun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"BS","family":"Chavan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/2229-516X.157162-1","unstructured":"American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorder. 4 th ed. Text Revision. Washington DC: American Psychiatric Association; 2000."},{"key":"key-10.4103\/2229-516X.157162-2","first-page":"1","volume-title":"Psychopharmacological treatment of oppositional defiant disorder","author":"Turgay","year":"2009","journal-title":"CNS Drugs"},{"key":"key-10.4103\/2229-516X.157162-3","first-page":"861","volume-title":"Oppositional defiant disorder","author":"Hamilton","year":"2008","journal-title":"Am Fam Physician"},{"key":"key-10.4103\/2229-516X.157162-4","first-page":"657","volume-title":"Current strategies in the diagnosis and treatment of childhood attention-deficit\/hyperactivity disorder","author":"Rader","year":"2009","journal-title":"Am Fam Physician"},{"key":"key-10.4103\/2229-516X.157162-5","first-page":"1715","volume-title":"Impact of comorbid oppositional or conduct problems on attention-deficit hyperactivity disorder","author":"Kuhne","year":"1997","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"key-10.4103\/2229-516X.157162-6","first-page":"253","volume-title":"Psychopharmacology and aggression.I: A meta-analysis of stimulant effects on overt\/covert aggression-related behaviors in ADHD","author":"Connor","year":"2002","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"key-10.4103\/2229-516X.157162-7","first-page":"603","volume-title":"Atomoxetine","author":"Unni","year":"2006","journal-title":"Indian Pediatr"},{"key":"key-10.4103\/2229-516X.157162-8","first-page":"45","volume-title":"Efficacy and safety of atomoxetine in childhood attention-deficit\/hyperactivity disorder with comorbid oppositional defiant disorder","author":"Kaplan","year":"2004","journal-title":"J Atten Disord"},{"key":"key-10.4103\/2229-516X.157162-9","first-page":"31","volume-title":"Effect of comorbid symptoms of oppositional defiant disorder on responses to atomoxetine in children with ADHD: A meta-analysis of controlled clinical trial data","author":"Biederman","year":"2007","journal-title":"Psychopharmacology (Berl)"},{"key":"key-10.4103\/2229-516X.157162-10","first-page":"e314","volume-title":"Atomoxetine for the treatment of attention-deficit\/hyperactivity disorder and oppositional defiant disorder","author":"Bangs","year":"2008","journal-title":"Pediatrics"},{"key":"key-10.4103\/2229-516X.157162-11","first-page":"240","volume-title":"Atomoxetine treatment in children and adolescents with attention-deficit\/hyperactivity disorder and comorbid oppositional defiant disorder","author":"Newcorn","year":"2005","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"key-10.4103\/2229-516X.157162-12","first-page":"822","volume-title":"Atomoxetine hydrochloride in the treatment of children and adolescents with attention-deficit\/hyperactivity disorder and comorbid oppositional defiant disorder: A placebo-controlled Italian study","author":"Dell\u2032Agnello","year":"2009","journal-title":"Eur Neuropsychopharmacol"},{"key":"key-10.4103\/2229-516X.157162-13","first-page":"97","volume-title":"Atomoxetine versus placebo in children and adolescents with attention-deficit\/hyperactivity disorder and comorbid oppositional defiant disorder: A double-blind, randomized, multicenter trial in Germany","author":"Dittmann","year":"2011","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"key-10.4103\/2229-516X.157162-14","first-page":"559","volume-title":"Psychometric properties of the Vanderbilt ADHD diagnostic parent rating scale in a referred population","author":"Wolraich","year":"2003","journal-title":"J Pediatr Psychol"},{"key":"key-10.4103\/2229-516X.157162-15","first-page":"981","volume-title":"Methylphenidate in children with oppositional defiant disorder and both comorbid chronic multiple tic disorder and ADHD","author":"Gadow","year":"2008","journal-title":"J Child Neurol"},{"key":"key-10.4103\/2229-516X.157162-16","first-page":"305","volume-title":"Clinical response to methylphenidate in children diagnosed with attention-deficit hyperactivity disorder and comorbid psychiatric disorders","author":"Ter-Stepanian","year":"2010","journal-title":"Can J Psychiatry"},{"key":"key-10.4103\/2229-516X.157162-17","first-page":"340","volume-title":"Effects of methylphenidate on aggressive urban children with attention deficit hyperactivity disorder","author":"Bukstein","year":"1998","journal-title":"J Clin Child Psychol"},{"key":"key-10.4103\/2229-516X.157162-18","first-page":"421","volume-title":"Long-acting methylphenidate has an effect on aggressive behavior in children with attention-deficit\/hyperactivity disorder","author":"Sinzig","year":"2007","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"key-10.4103\/2229-516X.157162-19","first-page":"399","volume-title":"The effect of methylphenidate on oppositional defiant disorder comorbid with attention deficit\/hyperactivity disorder","author":"Serra-Pinheiro","year":"2004","journal-title":"Arq Neuropsiquiatr"},{"key":"key-10.4103\/2229-516X.157162-20","first-page":"176","volume-title":"Comparative efficacy and acceptability of methylphenidate and atomoxetine in treatment of attention deficit hyperactivity disorder in children and adolescents: A meta-analysis","author":"Hanwella","year":"2011","journal-title":"BMC Psychiatry"}],"container-title":["International Journal of Applied and Basic Medical Research"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:31:38Z","timestamp":1786649498000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/2229-516X.157162"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015]]}},"alternative-id":["157162"],"URL":"https:\/\/doi.org\/10.4103\/2229-516x.157162","relation":{},"ISSN":["2229-516X"],"issn-type":[{"value":"2229-516X","type":"print"}],"subject":[],"published":{"date-parts":[[2015]]}}}